Drug Profile
Research programme: phosphodiesterase 10A inhibitors - Pfizer
Alternative Names: PF-03188212; PQ-10; TP-10Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Phosphodiesterase 10A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Psychotic disorders